2025 Breast Cancer SPORE Investigators Workshop (Poster Submission)

Filter submissions
3 submissions
# Created User IP address First Name Middle Initial Last Name Degree(s) Position/Title Organization Organization Address Email Posters should be based on the session topic chosen for your abstract submission. Please select your topic session: Upload Your Virtual Poster (mp4 format only and less than 100 MB) Poster Title Keywords Email To Share on Poster Listing Additional Authors Operations
2 Fri, 06/06/2025 - 16:19 Anonymous 10.208.24.225 Jamunarani Veeraraghavan Ph.D. Assistant Professor Baylor College of Medicine Houston jveerara@bcm.edu Session 7: Novel therapeutic targets Resistance to TDxd in HER2+ breast cancer: Models, Mechanisms and Treatment implications TDxd, Resistance, HER2+ breast cancer, tucatinib, EGFR rschiff@bcm.edu
  1. First Name: Jamunarani
    Last Name: Veeraraghavan
    Degree(s): Ph.D.
    Organization: Baylor College of Medicine
  2. First Name: Fu-Tien
    Last Name: Liao
    Degree(s): Ph.D.
    Organization: Baylor College of Medicine
  3. First Name: Caroline
    Last Name: Sabotta
    Degree(s): MS
    Organization: Baylor College of Medicine
  4. First Name: Lanfang
    Last Name: Qin
    Degree(s): Ph.D.
    Organization: Baylor College of Medicine
  5. First Name: Sarmistha
    Last Name: Nanda
    Degree(s): MS
    Organization: Baylor College of Medicine
  6. First Name: Mothaffar F.
    Last Name: Rimawi
    Degree(s): M.D.
    Organization: Baylor College of Medicine
  7. First Name: C. Kent
    Last Name: Osborne
    Degree(s): M.D.
    Organization: Baylor College of Medicine
  8. First Name: Rachel
    Last Name: Schiff
    Degree(s): Ph.D.
    Organization: Baylor College of Medicine
3 Fri, 06/06/2025 - 16:00 Anonymous 10.208.24.225 Diego A. Pedroza Ph.D. Baylor College of Medicine Houston diego.pedroza@bcm.edu Session 2: Understandings of tumor microenvironment and immunotherapies, Session 5: Early-stage investigators Anti-CSF1R therapy with combined immuno- chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched Triple Negative Breast Cancers. TNBC, macrophages, tumor immune microenvironment, metastases diego.pedroza@bcm.edu
  1. First Name: Xiang
    Middle Initial: H-F.
    Last Name: Zhang
    Degree(s): Ph.D.
    Organization: BCM
  2. First Name: Jeffrey
    Middle Initial: M.
    Last Name: Rosen
    Degree(s): Ph.D.
    Organization: BCM
1 Thu, 06/05/2025 - 16:58 Anonymous 10.208.24.39 Valentina Hoyos M.D. Associate Professor Baylor College of Medicine Houston hoyos@bcm.edu Session 2: Understandings of tumor microenvironment and immunotherapies Optimized HER2 Chimeric Antigen Receptor T cells (CAR-Ts) for the treatment of HER2 expressing metastatic breast cancer CAR-T cells, Immunotherapy, HER2 hoyos@bcm.edu
  1. First Name: Diego
    Last Name: Chamorro
    Degree(s): M.D.
    Organization: Baylor College of Medicine
  2. First Name: Natalie
    Last Name: Chen
    Degree(s): M.D., Ph.D.
    Organization: Baylor College of Medicine
  3. First Name: Nataly
    Last Name: Torrejon
    Degree(s): M.D.
    Organization: Baylor College of Medicine
  4. First Name: Saisha
    Last Name: Nalawade
    Degree(s): Ph.D.
    Organization: Baylor College of Medicine
  5. First Name: Mothaffar
    Last Name: Rimawi
    Degree(s): M.D.
    Organization: Baylor College of Medicine